Common genetic variation responsible for mediating SARS-CoV-2 asymptomatic infection

FHS
July 19, 2023
5:37 pm

Have you ever wondered why some people never became sick from COVID-19? A study published today in Nature shows that common genetic variation among people is responsible for mediating SARS-CoV-2 asymptomatic infection.

BioNTech CAR-T manufacturing change leads to fresh data with vaccine combo, with registrational trial plans: #ESMO23

MADRID — BioNTech is back with new data to support its BNT211 program in solid tumors after a manufacturing tweak. The company is now reviewing

October 24, 2023

CHMP recommends 14 new approvals, seven label expansions

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 1, 2024

As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA) – Biotech Investments

EQS Newswire / 22/01/2024 / 09:00 UTC+8 As A Breakthrough Drug For The Expansive Osteoporosis Market,Bogutai® (Teriparatide Injection) Has Been Officially Approved By The ChinaNational

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.